Onkologie. 2020:14(5):233-239 | DOI: 10.36290/xon.2020.080

Non-melanoma skin cancers

Alena Fialová
Dermatovenerologická klinika, FNKV, Praha

Non-melanoma skin cancers represent a group of tumors with one of the most common occurrence in the population. The guidelines of their treatment have been changing very dynamically in last years. Surgery remains as the first treatment choice, but new molecules significantly prolong life in the case of locally advanced or metastatic tumors. The goal of this article is to describe the problems of the most common non-melanoma skin cancers and use this information in clinical practice.

Keywords: basel cell carcinoma, dermatofibrosarcoma protuberans, Merkel cell carcinoma, cutaneous squamous cell carcinoma, surgery, radiotherapy, topical therapy, hedgehog inhibitor, checkpoint inhibitor, EGFR inhibitor, chemotherapy.

Published: November 19, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fialová A. Non-melanoma skin cancers. Onkologie. 2020;14(5):233-239. doi: 10.36290/xon.2020.080.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wang GY, Wang J, Mancianti ML, Epstein EH Jr. Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/-) mice. Cancer Cell. 2011; 19(1): 114-124. doi: 10.1016/j.ccr.2010.11.007. Go to original source... Go to PubMed...
    2. Krynitz B, Olsson H, Lundh Rozell B, Lindelöf B, Edgren G, Smedby KE. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study. Br J Dermatol. 2016; 174(1): 95-103. doi: 10.1111/bjd.14153. Go to original source... Go to PubMed...
    3. Pellegrini C, Maturo MG, Di Nardo L, Ciciarelli V, Gutiérrez García-Rodrigo C, Fargnoli MC. Understanding the Molecular Genetics of Basal Cell Carcinoma. Int J Mol Sci. 2017; 18(11): 2485. Published 2017 Nov 22. doi: 10.3390/ijms18112485. Go to original source... Go to PubMed...
    4. Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012. JAMA Dermatol 2015; 151(9): 976-981. Go to original source... Go to PubMed...
    5. Peris K, Fargnoli MC, Garbe C, et al. Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'. Eur J Cancer. 2020;131:100-103. doi: 10.1016/j.ejca.2020.02.040. Go to original source... Go to PubMed...
    6. Lallas A, Tzellos T, Kyrgidis A, et al. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma. J Am Acad Dermatol. 2014; 70(2): 303-311. doi: 10.1016/j.jaad.2013.10.003. Go to original source... Go to PubMed...
    7. Falchook GS, Leidner R, Stankevich E, et al. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810. J Immunother Cancer. 2016; 4: 70. Published 2016 Nov 15. doi: 10.1186/s40425-016-0176-3. Go to original source... Go to PubMed...
    8. Bednar B. Storiform neurofibromas of the skin, pigmented and nonpigmented. Cancer. 1957; 10(2): 368-376. doi: 10.1002/1097-0142(195703/04)10:23.0.co;2-3. Go to original source...
    9. Rouhani P, Fletcher CD, Devesa SS, Toro JR. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer. 2008; 113(3): 616-627. doi: 10.1002/cncr.23571 Go to original source... Go to PubMed...
    10. Saiag P, Grob JJ, Lebbe C, et al. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline. Eur J Cancer 2015; 51(17): 2604-2608. doi: 10.1016/j.ejca.2015.06.108. Go to original source... Go to PubMed...
    11. Coit DG. Merkel cell carcinoma. Ann Surg Oncol. 2001; 8(9 Suppl): 99S-102S. Go to original source... Go to PubMed...
    12. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010; 37(1): 20-27. doi: 10.1111/j.1600-0560.2009.01370.x. Go to original source... Go to PubMed...
    13. Lebbe C, Becker JC, Grob JJ, et al. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer. 2015; 51(16): 2396-2403. doi: 10.1016/j.ejca.2015.06.131 Go to original source... Go to PubMed...
    14. Amin MB, et al. AJCC cancer staging manual (Eighth Edition) Springer Switzerland (2017).
    15. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166(5): 1069-1080. doi: 10.1111/j.1365-2133.2012.10830.x. Go to original source... Go to PubMed...
    16. Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012; 106(7): 811-815. doi: 10.1002/jso.23155. Go to original source... Go to PubMed...
    17. Al-Rohil RN, Tarasen AJ, Carlson JA, et al. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies. Cancer 2016; 122(2): 249-257. doi: 10.1002/cncr.29738. Go to original source... Go to PubMed...
    18. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. squamous cell skin cancer. version 1.2020-October 2, 2019. Available at NCCN.org.
    19. Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention [published online ahead of print, 2020 Feb 26]. Eur J Cancer. 2020; S0959-8049(20)30018-6. doi: 10.1016/j.ejca.2020.01.007. Go to original source... Go to PubMed...
    20. Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment [published online ahead of print, 2020 Feb 26]. Eur J Cancer. 2020; S0959-8049(20)30019-8. doi: 10.1016/j.ejca.2020.01.008. Go to original source... Go to PubMed...
    21. Schaper K, Köther B, Hesse K, Satzger I, Gutzmer R. The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma. Br J Dermatol. 2017; 176(5): 1354-1356. doi: 10.1111/bjd.14955. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.